NCT07484022 2026-03-19
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Generate Biomedicines
Phase 1 Not yet recruiting
Clinical Trials
4 trialsNCT07421700 2026-02-19
A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Pfizer
Phase 1/2 Not yet recruiting
NCT07386847 2026-02-04
A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer
Pfizer
Not yet recruiting
NCT06912672 2025-04-08
UMT-UC
Shanghai Epiprobe Biotechnology Co., Ltd.
Not yet recruiting